Site-directed Mutagenesis Reveals Regions Implicated in the Stability and Fiber Formation of Human λ3r Light Chains*
暂无分享,去创建一个
E. Rudiño-Piñera | D. A. Fernández‐Velasco | R. Sánchez-López | B. Becerril | T. Olamendi‐Portugal | M. Villalba | J. Canul-Tec | O. D. Luna-Martinez | Rosalba Sánchez-Alcalá | Sonia Rojas
[1] Baltazar Becerril,et al. A single mutation at the sheet switch region results in conformational changes favoring lambda6 light-chain fibrillogenesis. , 2010, Journal of molecular biology.
[2] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[3] M. Ramirez-Alvarado,et al. Structural alterations within native amyloidogenic immunoglobulin light chains. , 2009, Journal of molecular biology.
[4] Charles Simon Bond,et al. ALINE: a WYSIWYG protein-sequence alignment editor for publication-quality alignments. , 2009, Acta crystallographica. Section D, Biological crystallography.
[5] A. Dispenzieri,et al. Mutations in Specific Structural Regions of Immunoglobulin Light Chains Are Associated with Free Light Chain Levels in Patients with AL Amyloidosis , 2009, PloS one.
[6] D. A. Fernández‐Velasco,et al. Thermodynamic and kinetic characterization of a germ line human lambda6 light-chain protein: the relation between unfolding and fibrillogenesis. , 2009, Journal of molecular biology.
[7] M. Ramirez-Alvarado,et al. Structural Insights into the Role of Mutations in Amyloidogenesis* , 2008, Journal of Biological Chemistry.
[8] D. A. Fernández‐Velasco,et al. Influence of the germline sequence on the thermodynamic stability and fibrillogenicity of human lambda 6 light chains , 2008, Proteins.
[9] B. Volkman,et al. Altered Dimer Interface Decreases Stability in an Amyloidogenic Protein* , 2008, Journal of Biological Chemistry.
[10] M. Ramirez-Alvarado,et al. Biochemical and aggregation analysis of Bence Jones proteins from different light chain diseases , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[11] K. Henrick,et al. Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.
[12] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[13] Narayanaswamy Srinivasan,et al. Nucleic Acids Research Advance Access published June 21, 2007 PIC: Protein Interactions Calculator , 2007 .
[14] Min Zhu,et al. Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. , 2007, Biochemistry.
[15] X. Daura,et al. AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides , 2007, BMC Bioinformatics.
[16] Flavio Seno,et al. Insight into the Structure of Amyloid Fibrils from the Analysis of Globular Proteins , 2006, PLoS Comput. Biol..
[17] G. Merlini,et al. Dangerous small B-cell clones. , 2006, Blood.
[18] H. Neumann,et al. Primary (AL) amyloidosis in plasma cell disorders. , 2006, The oncologist.
[19] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[20] P. Evans,et al. Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.
[21] G. Merlini,et al. Clinical aspects of systemic amyloid diseases. , 2005, Biochimica et biophysica acta.
[22] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[23] L. Serrano,et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.
[24] P. Adams,et al. Structural basis of light chain amyloidogenicity: comparison of the thermodynamic properties, fibrillogenic potential and tertiary structural features of four Vλ6 proteins , 2004, Journal of molecular recognition : JMR.
[25] Mateusz Nowak,et al. Immunoglobulin kappa light chain and its amyloidogenic mutants: A molecular dynamics study , 2004, Proteins.
[26] J. Wall,et al. Towards understanding the structure-function relationship of human amyloid disease. , 2004, Current drug targets.
[27] R. Fonseca,et al. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). , 2003, Blood.
[28] E. Ascari,et al. Analysis of Vλ-Jλ expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r(λIII) as a new amyloid-associated germline gene segment , 2002 .
[29] James C. Sacchettini,et al. Therapeutic strategies for human amyloid diseases , 2002, Nature Reviews Drug Discovery.
[30] J. Richardson,et al. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Martínez,et al. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden. , 2001, Blood.
[32] C. Soto,et al. Protein misfolding and disease; protein refolding and therapy , 2001, FEBS letters.
[33] G. Merlini,et al. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability. , 2000, Journal of structural biology.
[34] A G Leslie,et al. Biological Crystallography Integration of Macromolecular Diffraction Data , 2022 .
[35] M. Schell,et al. Thermodynamic instability of human lambda 6 light chains: correlation with fibrillogenicity. , 1999, Biochemistry.
[36] P. Saggau,et al. Simultaneous optical recording of membrane potential and intracellular calcium from brain slices. , 1999, Methods.
[37] P. Lipsky,et al. Molecular Mechanisms and Selection Influence the Generation of the Human VλJλ Repertoire , 1999, The Journal of Immunology.
[38] P. Lipsky,et al. Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. , 1999, Journal of immunology.
[39] C. Murphy,et al. In vitro immunoglobulin light chain fibrillogenesis. , 1999, Methods in enzymology.
[40] K. Olsen,et al. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. , 1998, Biochemical and biophysical research communications.
[41] Weiss,et al. Differences in kappa to lambda (κ:λ) ratios of serum and urinary free light chains , 1998 .
[42] D. Milardi,et al. An alternative approach in the structure-based predictions of the thermodynamics of protein unfolding. , 1997, Biophysical chemistry.
[43] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[44] M. Lefranc,et al. Sequence and evolution of the human germline V lambda repertoire. , 1996, Journal of molecular biology.
[45] M. Schiffer,et al. Pitfalls of molecular replacement: the structure determination of an immunoglobulin light-chain dimer. , 1996, Acta crystallographica. Section D, Biological crystallography.
[46] M. Schiffer,et al. Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light‐chain amyloid proteins , 1994, Protein science : a publication of the Protein Society.
[47] M. Schiffer,et al. Structure and properties of human immunoglobulin light-chain dimers. , 1995, Methods in molecular biology.
[48] M. Hurle,et al. A role for destabilizing amino acid replacements in light-chain amyloidosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[49] P. Lansbury,et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.
[50] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[51] L. Pearl,et al. Recursive PCR: a novel technique for total gene synthesis. , 1992, Protein engineering.
[52] S. Yadav,et al. MEASURING THE CONFORMATIONAL STABILITY OF PROTEINS , 1992 .
[53] H R Hoogenboom,et al. By-passing immunization. Human antibodies from V-gene libraries displayed on phage. , 1991, Journal of molecular biology.
[54] M. Hosokawa,et al. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. , 1989, Analytical biochemistry.
[55] R. Poljak,et al. Amino acid sequence of the variable region of the light (lambda) chain from human myeloma cryoimmunoglobulin IgG Hil. , 1978, Biochemistry.
[56] G J Williams,et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.